In this article, we break down the 5 Promising Small-Cap Biotech Stocks to Watch. For investors looking for the complete list, you can explore our full report on the 10 Promising Small-Cap Biotech Stocks to Watch.
5. Richtech Robotics Inc. (NASDAQ: RR)
Healthcare Robotics Ambitions Enter a Reset
Richtech Robotics Inc. (NASDAQ: RR) offers a healthcare automation angle, although its medical-sector strategy requires careful qualification. The business previously developed Medbot for transporting medications and essential supplies within healthcare facilities. Its fiscal 2025 annual report subsequently disclosed that the Medbot product line had been discontinued while new robotic technologies were being developed to better serve the healthcare sector.
That disclosure changes the investment story. The relevant question is how successfully its robotics capabilities can support a future healthcare offering. Presenting the discontinued product as an expanding hospital business would get ahead of the evidence.
The underlying opportunity remains practical. Hospital logistics involves repetitive movements of supplies, medications, and equipment, making it a potential application for autonomous delivery robots. However, an attractive use case becomes an investable business only when deployments demonstrate reliability, customer acceptance, and sustainable economics. Hospital corridors can provide an opportunity; they do not automatically provide a purchase order.
Subscription Growth Provides Context, Not Proof of Medical Sales
Richtech Robotics Inc. (NASDAQ: RR) reported approximately $3.9 million in total revenue for the nine months ended June 30, 2026, an increase of 9.6% year over year. Robots-as-a-Service revenue grew approximately 189.1% to roughly $1.1 million, demonstrating progress in its recurring service model.
Those figures describe the broader business. They should not be interpreted as healthcare revenue growth or evidence that a replacement for Medbot has achieved commercial adoption.
For investors researching healthcare robotics stocks, the next meaningful developments would include a clearly defined medical product, documented hospital deployments, and disclosure of the associated revenue opportunity. Until then, healthcare represents a development ambition within a wider commercial robotics operation.
Ranking Rationale
Richtech Robotics Inc. (NASDAQ: RR) retains the No. 5 position in the supplied countdown because its recurring revenue model offers a commercial foundation, while its healthcare strategy remains less established than an operating hospital robotics platform. The discontinued Medbot line and limited visibility into replacement products warrant a measured assessment of its medical automation potential.
